Gunnar Kristensen

Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis

Yiling Lu, Gordon B. Mills, G. Mills, 2009, PloS one.

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

Corneel Coens, Alan Lamont, Gordon C Jayson, 2010, The Lancet.

A phase 3 trial of bevacizumab in ovarian cancer.

Jacobus Pfisterer, Jalid Sehouli, Rainer Kimmig, 2011, The New England journal of medicine.

High‐resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas

Patrick G Buckley, A. Børresen-Dale, J. Dumanski, 2005, Genes, chromosomes & cancer.

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Jacobus Pfisterer, Gordon C Jayson, Michael Quinn, 2015, The Lancet. Oncology.